Package Leaflet: Information for the User
Rivaroxaban Bluefish 15 mg + 20 mg film-coated tablets EFG
Starter Pack for Treatment Initiation
Not for use in children
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
Rivaroxaban Bluefish contains the active substance rivaroxaban. Rivaroxaban is used in adults to:
Rivaroxaban belongs to a group of medications called antithrombotic agents. It works by blocking a clotting factor (factor Xa) and thus reducing the tendency of blood to form clots.
Do not take Rivaroxaban Bluefish
Do not take rivaroxaban and inform your doctorif any of these circumstances apply to you.
Warnings and precautions
Consult your doctor or pharmacist before starting to take rivaroxaban.
Be particularly careful with Rivaroxaban Bluefish
Inform your doctor if you have any of these situationsbefore taking rivaroxaban. Your doctor will decide if you should be treated with this medication and if you should be kept under closer observation.
If you need surgery
Children and adolescents
The starter pack for rivaroxaban treatment is not recommended for persons under 18 years of age, as it is specifically designed for the initiation of treatment in adult patients and is not suitable for use in children and adolescents.
Other medications and Rivaroxaban Bluefish
Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication, including medications obtained without a prescription.
If any of the above circumstances apply to you, inform your doctorbefore taking rivaroxaban, as the effect of rivaroxaban may be increased. Your doctor will decide if you should be treated with this medication and if you should be kept under closer observation.
If your doctor considers that you have a higher risk of developing a stomach or intestinal ulcer, they may recommend that you also use a preventive treatment.
If any of the above circumstances apply to you, inform your doctorbefore taking rivaroxaban, as the effect of rivaroxaban may be reduced. Your doctor will decide if you should be treated with this medication and if you should be kept under closer observation.
Pregnancy and breastfeeding
Do not take rivaroxaban if you are pregnant or breastfeeding. If there is any possibility that you may become pregnant, use a reliable contraceptive while taking rivaroxaban. If you become pregnant while taking this medication, inform your doctor immediately, who will decide how you should be treated.
Driving and using machines
Rivaroxaban may cause dizziness (a frequent side effect) or fainting (a rare side effect) (see section 4 "Possible side effects"). You should not drive, ride a bicycle, or use tools or machines if you are affected by these symptoms.
Rivaroxaban Bluefish contains lactose and sodium
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
This medication contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
Follow the instructions for administration of this medication exactly as indicated by your doctor or pharmacist. If you are in doubt, consult your doctor or pharmacist again.
You must take rivaroxaban with food. Swallow the tablets, preferably with water.
If you have difficulty swallowing the tablet whole, consult your doctor about other ways to take rivaroxaban. The tablet can be crushed and mixed with water or apple sauce, immediately before taking it. Then, take food.
If necessary, your doctor may also administer the crushed rivaroxaban tablet through a gastric tube.
What dose to take
The recommended dose is one 15 mg rivaroxaban tablet twice a day for the first 3 weeks. For treatment after 3 weeks, the recommended dose is one 20 mg rivaroxaban tablet once a day.
This starter pack for rivaroxaban treatment with 15 mg and 20 mg is only for the first 4 weeks of treatment.
Once this pack is finished, treatment will continue with rivaroxaban 20 mg once a day, as indicated by your doctor.
If you have kidney problems, your doctor may decide to reduce the dose of the treatment to one 15 mg rivaroxaban tablet once a day after 3 weeks if the risk of bleeding is higher than the risk of having another blood clot.
When to take Rivaroxaban Bluefish
Take the tablets every day, until your doctor indicates otherwise.
Try to take the tablets at the same time every day to remember when to take them.
Your doctor will decide how long you should continue taking the treatment.
If you take more Rivaroxaban Bluefish than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medication and the amount ingested.
Call your doctor immediately if you have taken too many rivaroxaban tablets. Taking too much rivaroxaban increases the risk of bleeding.
If you forget to take Rivaroxaban Bluefish
If you stop taking Rivaroxaban Bluefish
Do not stop taking rivaroxaban without consulting your doctor first, as rivaroxaban treats and prevents serious conditions.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them.
Like other similar medications for reducing blood clot formation, rivaroxaban may cause bleeding that can put the patient's life at risk. Excessive bleeding can cause a sudden drop in blood pressure (shock). In some cases, the bleeding may not be apparent.
Inform your doctor immediatelyif you experience any of the following symptoms:
Your doctor may decide to keep you under closer observation or change your treatment.
The frequency of these side effects is very rare (up to 1 in 10,000 people).
The frequencies of severe allergic reactions are very rare (anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 people) and uncommon (angioedema and allergic edema; may affect up to 1 in 100 people).
General list of possible side effects
Frequent(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
(inflammation or liver damage)
Very rare(may affect up to 1 in 10,000 people)
Frequency not known(cannot be estimated from available data)
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after CAD or EXP. The expiry date is the last day of the month stated.
This medicine does not require any special storage conditions.
Crushed tablets
Crushed tablets are stable in water or apple sauce for up to 4 hours.
Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the SIGRE collection point at your pharmacy. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Rivaroxaban Bluefish
Tablet core: microcrystalline cellulose, sodium croscarmellose, lactose monohydrate, hypromellose, sodium lauryl sulfate, magnesium stearate.
Coating: macrogol, hypromellose, titanium dioxide (E171), red iron oxide (E172).
Appearance and package contents of the product
Rivaroxaban Bluefish 15 mg film-coated tablets are biconvex, round, red tablets, marked with “1” on one side and with a diameter of approximately 5 mm.
Rivaroxaban Bluefish 20 mg film-coated tablets are biconvex, round, reddish-brown tablets, marked with a “2” on one side.
Initial treatment pack for the first 4 weeks of treatment containing PVC/PVdC//Al blisters of 49 film-coated tablets:
Marketing authorisation holder
Bluefish Pharmaceuticals AB
P.O. Box 49013
100 28 Stockholm
Sweden
Manufacturer
Sofarimex-Indústria Química e Farmacêutica, S.A.
Avenida das Indústrias, Alto de Colaride,
2735-213 Cacém, Portugal.
You can request more information about this medicine by contacting the local representative of the marketing authorisation holder.
Bluefish Pharma S.L.U.,
AP 36007, 2832094 Madrid,
Sucursal 36
This medicine is authorised in other EEA countries under the following names
Germany | Rivaroxaban Bluefish 15 mg + 20 mg Filmtabletten |
Austria | Rivaroxaban Bluefish 15 mg + 20 mg Filmtabletten |
Denmark | Rivaroxaban Bluefish 15 mg + 20 mg filmovertrukne tabletter |
Spain | Rivaroxabán Bluefish 15 mg + 20 mg comprimidos recubiertos con película EFG |
France | Rivaroxaban Bluefish 15 mg + 20 mg comprimés pelliculés |
Ireland | Rivaroxaban Bluefish 15 mg + 20 mg film-coated tablets |
Iceland | Rivaroxaban Bluefish 15 mg + 20 mg filmuhúðaðar töflur |
Norway | Rivaroxaban Bluefish 15 mg + 20 mg tabletter, filmdrasjerte |
Poland | Rivaroxaban Bluefish |
Portugal | Rivaroxaban Bluefish |
United Kingdom (NI) | Rivaroxaban Bluefish 15 mg + 20 mg film-coated tablets |
Sweden | Rivaroxaban Bluefish |
Date of last revision of this leaflet:January 2024
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).